Literature DB >> 9337180

The Münster Heart Study (PROCAM): total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers.

P Cullen1, H Schulte, G Assmann.   

Abstract

BACKGROUND: Some large epidemiological studies have shown an increase in mortality at low levels of total and LDL cholesterol. It has been speculated that low cholesterol levels may play a causative role in this association. To investigate this question, we analyzed all deaths occurring among middle-aged men in the Münster Heart Study (PROCAM), one of the largest prospective epidemiological studies of coronary heart disease risk markers in Europe. METHODS AND
RESULTS: In the Münster Heart Study, 10,856 men aged 36 to 65 years at study entry (46.8+/-7.3 years [mean+/-SD]) were followed for 4 to 14 years (7.1+/-2.4 years). During this period, 313 deaths occurred--46 from myocardial infarction, 48 from suspected or definite sudden cardiac death, 14 from cerebrovascular disease, and 10 from other diseases of the circulatory system. There were 121 deaths from cancer and 33 deaths from violent causes (injuries in 16, suicide in 14, and homicide in 3 cases). Death in 29 cases occurred from other causes and was unexplained in 12 cases. Total cholesterol, LDL cholesterol, and the LDL/HDL ratio showed a J-shaped relationship with total mortality. At high total and LDL cholesterol concentrations, increased mortality was due to increased coronary deaths. At low total and LDL cholesterol concentrations, increased mortality was seen in smokers only and was explained by an increase in smoking-related cancer deaths.
CONCLUSIONS: The increase in mortality at low levels of total and LDL cholesterol among middle-aged men in the Münster Heart Study is explained by an increase in smoking-related cancer deaths among smokers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9337180     DOI: 10.1161/01.cir.96.7.2128

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

Review 1.  Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Authors:  Martin Hersberger; Arnold von Eckardstein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease.

Authors:  Meliana Riwanto; Ulf Landmesser
Journal:  J Lipid Res       Date:  2013-07-20       Impact factor: 5.922

Review 3.  Consensus statement on management of dyslipidemia in Indian subjects.

Authors:  K Sarat Chandra; Manish Bansal; Tiny Nair; S S Iyengar; Rajeev Gupta; Subhash C Manchanda; P P Mohanan; V Dayasagar Rao; C N Manjunath; J P S Sawhney; Nakul Sinha; A K Pancholia; Sundeep Mishra; Ravi R Kasliwal; Saumitra Kumar; Unni Krishnan; Sanjay Kalra; Anoop Misra; Usha Shrivastava; Seema Gulati
Journal:  Indian Heart J       Date:  2014-12-24

4.  Efficacy, safety and tolerability of combined low-dose simvastatin-fenofibrate treatment in primary mixed hyperlipidaemia.

Authors:  C Stefanutti; A Bucci; S Di Giacomo; N Fraone; A Pace; M Mareri; A Musca; A Mammarella
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

5.  Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study.

Authors:  Evangelos Kontopantelis; David A Springate; David Reeves; Darren M Ashcroft; Martin K Rutter; Martin Rutter; Iain Buchan; Tim Doran
Journal:  Diabetologia       Date:  2014-12-16       Impact factor: 10.122

Review 6.  Coronary CT and the coronary calcium score, the future of ED risk stratification?

Authors:  Leticia Fernandez-Friera; Ana Garcia-Alvarez; Gabriela Guzman; Mario J Garcia
Journal:  Curr Cardiol Rev       Date:  2012-05

7.  Rosuvastatin and atorvastatin: comparative effects on glucose metabolism in non-diabetic patients with dyslipidaemia.

Authors:  Ahmed Abbas; John Milles; Sudarshan Ramachandran
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2012-02-20

8.  Dyslipidaemia in hypertensive obese type 2 diabetic patients in Jamaica.

Authors:  Lorenzo Gordon; Dalip Ragoobirsingh; Errol Morrison; Donovan McGrowder; Eric Choo-Kang; E Martorell
Journal:  Arch Med Sci       Date:  2010-10-26       Impact factor: 3.318

9.  Reduced coenzyme Q(10) in female smokers and its association with lipid profile in a young healthy adult population.

Authors:  Maha M Al-Bazi; Mohamed F Elshal; Samir M Khoja
Journal:  Arch Med Sci       Date:  2011-12-30       Impact factor: 3.318

10.  Whole body bone tissue and cardiovascular risk in rheumatoid arthritis.

Authors:  Claudiu Popescu; Violeta Bojincă; Daniela Opriş; Ruxandra Ionescu
Journal:  J Osteoporos       Date:  2014-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.